On May 23, special guest Nagla Karim, MD, from the Inova Schar Cancer Institute, spoke with us about the application of subtyping and biomarkers for SCLC.
Moderated by Misty Shields, MD, PhD, IU Health, and LUNGevity’s Ann Fish-Steagall, SVP of Patient Services and Health Care Delivery, the monthly Small Cell SMASHERS series highlights the latest discoveries and breakthroughs for SCLC.